A whole-exome sequencing study confirmed that PD patients carrying deleterious PER1 variants exhibited a higher incidence of dyskinesia, highlighting these variants as critical risk factors for PD-related motor symptoms (58). The gene discussed is PER1; the disease is drug-induced dyskinesia.